NemerPharma Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

NemerPharma General Information

Description

Manufacturer of medicines designed for the treatment of neuropathic and cancer-related pain. The company's products uses an alternative of TTX as a pharmaceutical ingredient, enabling cancer patients to reduce their medical bills.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Erik Dahlbergsgatan 11A
  • 411 26 Gothenburg
  • Sweden
+46 031-786 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NemerPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 08-Oct-2010 Completed Startup
To view NemerPharma’s complete valuation and funding history, request access »

NemerPharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GU Ventures Accelerator/Incubator Minority 000 0000 000000 0
To view NemerPharma’s complete investors history, request access »